Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. - Wikidata - awgldk - TriplyDB

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

http://www.wikidata.org/entity/Q36115781

about

Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer Targeting ECM Disrupts Cancer Progression Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression Interlobular and intralobular mammary stroma: genotype may not reflect phenotype 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer.14-3-3Tau regulates Beclin 1 and is required for autophagy.14-3-3τ promotes breast cancer invasion and metastasis by inhibiting RhoGDIα Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells Prognostic role of CIP2A expression in serous ovarian cancer Annexin A2 promotes glioma cell invasion and tumor progression Tenascin C in metastasis: A view from the invasive front Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation Tenascin-C in primary Merkel cell carcinoma.Involvement of large tenascin-C splice variants in breast cancer progression Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer.Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.Breast cancer cell-derived matrix supports vascular morphogenesis.Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms How do tenascins influence the birth and life of a malignant cell?SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.mTOR signal transduction pathways contribute to TN-C FNIII A1 overexpression by mechanical stress in osteosarcoma cells High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer.WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.Expression of tenascin-C and its isoforms in the breast.Stromal biomarkers in breast cancer development and progression.Priming cancer cells for drug resistance: role of the fibroblast niche.Tenascin-C aptamers are generated using tumor cells and purified protein.Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy.Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion.Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.

P2860

Q24672629-D0AFAF13-AC18-4DD0-B585-1D8F03765A8C Q26779300-320FFE02-A6EB-45D2-AF96-19C81F1009C7 Q27023385-A60FE4EB-3E5F-4BE0-89ED-4D6259CD103E Q28822348-35B72498-A24D-44A4-B3DA-1B66F03FA661 Q33361045-38D9E106-6926-4DB4-AB1B-0C88024F54EF Q33705055-4D58F1BA-1415-43F6-B42C-ED9F84B4C417 Q33818362-4F43C121-84FD-4449-B58D-0D8B90027890 Q33899871-DAF7083F-A4BD-401E-8C8E-E09E22AA25A6 Q34173505-71CB8B54-F368-4577-BA40-78F37F5E902C Q34296481-34340392-07FA-4F9B-A139-23A3A848BE55 Q34454213-03E922E2-DB7F-4ADC-8483-D8E959814ECB Q34756114-CE993C45-6E01-4EF8-8AF4-F26DA022E2EB Q35263210-C8267B57-79D5-4464-A22A-1B94171D78A1 Q35448499-B808FFBB-E020-4D96-937B-2B1EEBAF5B84 Q35577928-ED282B90-E78B-4051-8A22-761BAC72BCDA Q35588136-32A30F55-1E82-4F24-AB70-8C2722052EB0 Q35588420-DE3999A4-0DC2-4F37-A567-7322992AFF67 Q35791432-0867AE0D-FFDE-4B06-8386-08460E49927D Q36070908-8E1AC1D9-C021-4FA6-B0A9-6AC324870FB5 Q36230697-BAA07362-F425-41F0-AC42-F44C32445A5B Q36364237-5BF007A4-54E7-4FD8-A0C8-E67E36B81952 Q36620181-37813AA4-DCEF-467E-A51C-6E560977F267 Q36695240-7DB9B546-E608-4254-A3C6-710440A38C64 Q37164157-C0A92A0F-9CC4-4DED-B3A0-2CC139331EEF Q37175709-53B38255-A566-4EF1-B99A-2672986A874D Q37190491-0D73FBF4-43D2-44C7-9EA0-824B7B42F218 Q37208797-32045900-84A2-4A6F-BF72-682B81D1B01D Q37295200-4353F67B-86D4-4C31-B13B-9B74A464BBE0 Q37600466-ADD64F2A-6978-471D-A89F-71B27A28B92A Q37604821-EA193049-58E5-4EC1-86A6-F38E1DFF65EF Q37688210-70C00980-8BDA-4D5D-BC96-FEA68E8B8431 Q37721627-9A14E379-DA49-475A-99F4-673E6BBEC64B Q37785009-F7697C46-6206-40ED-9CF1-6692829BA788 Q38017601-B4BBA59E-0572-4414-840C-EEDFE42C6081 Q38232067-1213CDCF-45E3-46E0-8B53-D199383CCE1A Q38296050-A85D1954-6704-405C-B237-C7203787A347 Q38522096-A6D885CF-57E9-4EBB-83CA-7F3FF2428202 Q39588142-279F4D4A-EF37-42A9-9A12-B94878553A6E Q40487608-75EA4B9D-6633-4D7B-83B6-5294F31225F4 Q40505626-0B864F0D-866E-47C2-A7D3-131CDD420EDB

P2860

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

http://www.wikidata.org/entity/Q36115781

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Tenascin-C expression in invas ...... local and distant recurrence.

@ast

Tenascin-C expression in invas ...... local and distant recurrence.

@en

type

label

Tenascin-C expression in invas ...... local and distant recurrence.

@ast

Tenascin-C expression in invas ...... local and distant recurrence.

@en

prefLabel

Tenascin-C expression in invas ...... local and distant recurrence.

@ast

Tenascin-C expression in invas ...... local and distant recurrence.

@en

P1433

Q36115781-D48E0715-FCA3-42D6-AB4E-004896491CA0

P1476

Q36115781-C5A97EF1-C8BF-4FC9-9C6F-BA296F0FF776

P2093

Q36115781-2D2743A3-039B-4A5E-9955-8B1F8DC71EDA

Q36115781-36920631-A9D4-4517-855F-3FE2757A4AE0

Q36115781-475F04CF-FF35-4DAB-AF24-B902F55517E9

Q36115781-5048B046-4A96-4BD4-89BA-7A2438F9E491

Q36115781-747F44DC-F510-4B90-8FF7-412C7D4F0274

Q36115781-DB0906B4-3C2C-4120-9837-34E691A80772

Q36115781-FCBB1CE5-654E-456D-84DF-F21DC1CEC6CE

P2860

Q36115781-1A5A5C43-DC5D-4EB1-9146-0653B02D0DA1

Q36115781-1AB304A7-C06A-4F83-AE0A-18434E0638A1

Q36115781-29BC4F12-A370-4336-9044-906996280B4A

Q36115781-3FA4752E-010B-4AAB-835D-4A5FD36EEDA2

Q36115781-4923FA20-0299-4BDA-A6B9-7EA202BCCEC2

Q36115781-49C4EC52-45A9-4603-92A7-B5FEE94FF6C0

Q36115781-50851441-7475-4DED-9E2B-5182D0CC1910

Q36115781-561676DC-3722-4718-8D7D-60EF093B35E0

Q36115781-6045987C-28B7-467A-909C-7797084E162A

Q36115781-66728D07-EC5E-4D9D-B5D9-7BA13DD74E64

P2888

Q36115781-CA911207-5B0D-4CF4-9286-F281DDE8DBCF

P304

Q36115781-61E619CC-33FF-4DEE-A886-C5B71D2210D3

P31

Q36115781-1ABB7026-1E2F-43B5-89B6-3998088FD7CD

P356

Q36115781-FD10254B-BA09-4C1C-87A5-077999D7C3DA

P407

Q36115781-169FB167-D216-462F-AA55-88416730331C

P433

Q36115781-6C36E8BA-D2DF-4FFC-9F2E-C7A494BB104E

P478

Q36115781-28997F8B-8FC4-4292-98C0-A6AF1739DF67

P50

Q36115781-8590A03D-BF2B-43AD-8FB9-CF36922155C6

Q36115781-9504541B-01DC-4D63-8FA8-D7AFC19DC9A6

P577

Q36115781-268DD793-DAC7-4977-96FC-338E356C0B20

P5875

Q36115781-715C6CE2-42BC-401C-94DE-89E645769129

P698

Q36115781-C8C4188E-5105-4492-BD20-BA63AE95703D

P932

Q36115781-A5CE4EBD-EC61-4676-90EC-6E7E43A85816

P356

P1433

British Journal of Cancer

P1476

Tenascin-C expression in invas ...... local and distant recurrence.

@en

P2093

Haglund C

http://www.w3.org/2001/XMLSchema#string

Jahkola T

http://www.w3.org/2001/XMLSchema#string

Nordling S

http://www.w3.org/2001/XMLSchema#string

Toivonen T

http://www.w3.org/2001/XMLSchema#string

Virtanen I

http://www.w3.org/2001/XMLSchema#string

von Boguslawski K

http://www.w3.org/2001/XMLSchema#string

von Smitten K

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data.

Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.

Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.

Tenascin in mammary gland development: from embryogenesis to carcinogenesis.

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Local control following breast-conserving surgery for invasive cancer: results of clinical trials.

Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis?

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review.

Prognostic factors in early breast carcinoma.

P2888

P304

1507-1513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1998.714

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Heli Nevanlinna

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13449952

http://www.w3.org/2001/XMLSchema#string

P698

9836485

http://www.w3.org/2001/XMLSchema#string

P932

2063217

http://www.w3.org/2001/XMLSchema#string